Tirzepatide is a synthetic peptide medication derived from the structure of human gastric inhibitory polypeptide (GIP), engineered to activate both GIP and glucagon-like peptide-1 (GLP-1) receptors
Key takeaways GLP-1 medications do not inherently cause muscle wasting. Most weight lost on semaglutide or tirzepatide is fat , not muscle. Some lean-mass loss during weight loss reflects adaptive remodeling , not pathology. Adequate protein intake and resistance training significantly reduce muscle loss during GLP-1 therapy. Do GLP-1 Medications Cause Muscle Wasting
Hair, nails, and skin: differentiating cutaneous manifestations of micronutrient deficiency
Ann N Y Acad Sci 1446(1):4465
The general recommendation is moderation, as both treatments can alter alcohol tolerance and increase the risk of hypoglycemia when combined with alcohol
This is followed by curving of the membrane and formation of an internalized clathrin-coated vesicle